Literature DB >> 12765848

"Loss of function" mutations in the cationic trypsinogen gene (PRSS1) may act as a protective factor against pancreatitis.

Jian-Min Chen1, Cedric Le Maréchal, Danièle Lucas, Odile Raguénès, Claude Férec.   

Abstract

Several genetic factors have been well known to predispose one to chronic pancreatitis (CP). However, little is known about the genetic factors that may provide a protective effect against the disease. Having found a nonsense mutation (c.111C>A; Y37X) and a splicing mutation (IVS2+1G>A) in the cationic trypsinogen gene (protease, serine, 1; PRSS1) in alcoholics without the development of CP, but not in alcoholics with CP and patients with hereditary or idiopathic CP, we propose that while "gain of function" mutations in the PRSS1 gene predispose one to pancreatitis, "loss of function" mutations in the gene may protect one against the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12765848     DOI: 10.1016/s1096-7192(03)00050-7

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  9 in total

Review 1.  Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis.

Authors:  Niels Teich; Jonas Rosendahl; Miklós Tóth; Joachim Mössner; Miklós Sahin-Tóth
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

Review 2.  Human cationic trypsinogen (PRSS1) variants and chronic pancreatitis.

Authors:  Balázs Csaba Németh; Miklós Sahin-Tóth
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-01-23       Impact factor: 4.052

3.  The -409 C/T genotype of PRSS1 protects against pancreatic cancer in the Han Chinese population.

Authors:  Qicai Liu; Xinhua Lin; Jingfeng Liu; Ailin Liu; Feng Gao
Journal:  Dig Dis Sci       Date:  2011-09-16       Impact factor: 3.199

4.  A Thai family with hereditary pancreatitis and increased cancer risk due to a mutation in PRSS1 gene.

Authors:  Theeraphong Pho-Iam; Wanna Thongnoppakhun; Pa-Thai Yenchitsomanus; Chanin Limwongse
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

Review 5.  Trypsinogen (PRSS1 and PRSS2) gene dosage correlates with pancreatitis risk across genetic and transgenic studies: a systematic review and re-analysis.

Authors:  Wen-Bin Zou; David N Cooper; Emmanuelle Masson; Na Pu; Zhuan Liao; Claude Férec; Jian-Min Chen
Journal:  Hum Genet       Date:  2022-01-28       Impact factor: 5.881

Review 6.  Acute pancreatitis and organ failure: pathophysiology, natural history, and management strategies.

Authors:  Michael G T Raraty; Saxon Connor; David N Criddle; Robert Sutton; John P Neoptolemos
Journal:  Curr Gastroenterol Rep       Date:  2004-04

7.  Association of rare chymotrypsinogen C (CTRC) gene variations in patients with idiopathic chronic pancreatitis.

Authors:  Emmanuelle Masson; Jian-Min Chen; Virginie Scotet; Cédric Le Maréchal; Claude Férec
Journal:  Hum Genet       Date:  2008-01-03       Impact factor: 4.132

8.  Hereditary pancreatitis caused by a double gain-of-function trypsinogen mutation.

Authors:  Emmanuelle Masson; Cédric Le Maréchal; Richard Delcenserie; Jian-Min Chen; Claude Férec
Journal:  Hum Genet       Date:  2008-05-07       Impact factor: 4.132

9.  Expanding ACMG variant classification guidelines into a general framework.

Authors:  Emmanuelle Masson; Wen-Bin Zou; Emmanuelle Génin; David N Cooper; Gerald Le Gac; Yann Fichou; Na Pu; Vinciane Rebours; Claude Férec; Zhuan Liao; Jian-Min Chen
Journal:  Hum Genomics       Date:  2022-08-16       Impact factor: 6.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.